ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Michael Cho. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Michael Cho reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:XTLB / XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock) 10% Owner 3,072,560
US:BPA / 7,250
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Michael Cho. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas ANIP / ANI Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ANIP / ANI Pharmaceuticals, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2004-08-16 BPA EDELMAN JOSEPH 200 5.1000 200 5.1000 1,020 730

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
Vendas Internas ANIP / ANI Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ANIP / ANI Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2004-08-16 BPA EDELMAN JOSEPH 200 5.5000 200 5.5000 1,100 730

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Michael Cho conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2008-06-19 2008-06-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 2,040 3,072,560 0.07 3.23 6,589 9,924,369
2008-06-19 2008-06-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 48,960 57,558,070 0.09 3.23 158,141 185,912,566
2008-06-11 2008-06-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 1,340 3,070,520 0.04 3.36 4,502 10,316,947
2008-06-11 2008-06-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 32,260 57,509,110 0.06 3.36 108,394 193,230,610
2008-06-11 2008-06-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 4,000 3,069,180 0.13 3.43 13,720 10,527,287
2008-06-11 2008-06-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 96,000 57,476,850 0.17 3.43 329,280 197,145,596
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 8,000 3,065,180 0.26 3.15 25,200 9,655,317
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 4,000 3,057,180 0.13 3.37 13,480 10,302,697
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 192,000 57,380,850 0.34 3.15 604,800 180,749,678
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinarry Shares
P - Purchase 96,000 57,188,850 0.17 3.37 323,520 192,726,424
2008-05-06 2008-05-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 2,000 3,036,140 0.07 3.88 7,760 11,780,223
2008-05-06 2008-05-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 48,000 56,683,890 0.08 3.88 186,240 219,933,493
2008-05-06 2008-05-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 4,200 3,034,140 0.14 3.75 15,750 11,378,025
2008-05-06 2008-05-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 100,800 56,635,890 0.18 3.75 378,000 212,384,588
2008-04-16 2008-04-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 10,000 3,015,650 0.33 3.56 35,579 10,729,381
2008-04-16 2008-04-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 90,000 56,191,770 0.16 3.58 322,011 201,048,534
2008-03-20 2008-03-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,650 2,984,350 0.22 3.12 20,749 9,311,769
2008-03-20 2008-03-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 156,350 55,797,070 0.28 3.12 487,843 174,098,018
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 12,000 2,977,700 0.40 3.32 39,856 9,889,835
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 15,780 2,965,700 0.53 3.33 52,566 9,879,340
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 188,000 55,640,720 0.34 3.32 624,404 184,799,523
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 247,220 55,452,720 0.45 3.33 823,539 184,724,101
2008-03-20 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,000 2,949,920 0.20 3.37 20,240 9,950,965
2008-03-20 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 8,820 2,943,920 0.30 3.38 29,814 9,951,333
2008-03-20 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 9,000 2,935,100 0.31 3.37 30,295 9,879,840
2008-03-20 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 17,400 2,926,100 0.60 3.35 58,292 9,802,728
2008-03-19 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 94,000 55,205,500 0.17 3.37 317,090 186,224,713
2008-03-19 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 138,180 55,111,500 0.25 3.38 467,090 186,293,403
2008-03-19 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 272,600 54,973,320 0.50 3.35 913,237 184,166,119
2008-03-19 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 141,000 54,700,720 0.26 3.37 474,620 184,128,094
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 11,900 2,908,700 0.41 3.30 39,327 9,612,672
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 30,000 2,896,800 1.05 3.31 99,351 9,593,333
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 107,100 54,559,720 0.20 3.30 353,944 180,308,963
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 470,000 54,452,620 0.87 3.31 1,556,499 180,330,742
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 25,200 2,866,800 0.89 3.28 82,568 9,393,070
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 30,000 2,841,600 1.07 3.15 94,500 8,951,040
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 30,000 2,811,600 1.08 3.25 97,368 9,125,329
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 394,800 5,398,260 7.89 3.28 1,293,562 17,687,399
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 470,000 53,587,820 0.88 3.15 1,480,500 168,801,633
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 470,000 53,117,820 0.89 3.25 1,525,432 172,399,197
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 60,000 2,781,600 2.20 3.74 224,268 10,397,064
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 9,020 2,721,600 0.33 3.65 32,893 9,924,859
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 141,440 52,647,820 0.27 3.65 515,789 191,990,805
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 940,000 52,506,380 1.82 3.74 3,513,532 196,258,347
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 39,300 2,712,580 1.47 3.86 151,824 10,479,239
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 15,600 2,673,280 0.59 3.73 58,146 9,964,117
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 244,400 51,566,380 0.48 3.73 910,952 192,203,368
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 615,700 51,321,980 1.21 3.86 2,378,572 198,267,073
2008-03-10 2008-03-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 34,200 2,657,680 1.30 3.94 134,700 10,467,538
2008-03-10 2008-03-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 535,800 50,706,280 1.07 3.94 2,110,302 199,711,754
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,640 2,623,480 0.25 3.99 26,490 10,466,111
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 18,000 2,616,840 0.69 3.98 71,656 10,417,378
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 282,000 50,170,480 0.57 3.98 1,122,614 199,723,664
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 104,060 49,888,480 0.21 3.99 415,137 199,025,102
2008-02-29 2008-02-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,600 2,598,840 0.25 4.01 26,484 10,428,365
2008-02-29 2008-02-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 103,400 49,784,420 0.21 4.01 414,913 199,769,942
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 3,790 2,592,240 0.15 3.95 14,970 10,239,348
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 24,000 2,588,450 0.94 3.91 93,742 10,110,227
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 59,390 49,681,020 0.12 3.95 234,590 196,240,029
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 376,000 49,621,630 0.76 3.91 1,468,618 193,817,125
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 46,500 2,564,450 1.85 3.87 179,871 9,919,805
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,000 2,517,950 0.24 3.86 23,159 9,718,783
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 94,000 49,245,630 0.19 3.86 362,821 190,078,283
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 728,500 49,151,630 1.50 3.87 2,817,984 190,128,335
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 12,000 2,511,950 0.48 3.95 47,431 9,928,734
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 30,000 2,499,950 1.21 3.95 118,374 9,864,303
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 28,380 2,469,950 1.16 3.95 112,101 9,756,302
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 188,000 48,432,130 0.39 3.95 743,089 191,432,837
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 470,000 48,235,130 0.98 3.95 1,854,526 190,326,176
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 444,620 47,765,130 0.94 3.95 1,756,249 188,672,264
2008-02-22 2008-02-20 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 100 2,441,570 0.00 3.84 384 9,375,629
2008-02-22 2008-02-20 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 900 47,320,510 0.00 3.84 3,456 181,710,758
2008-02-19 2008-02-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 360 2,441,470 0.01 3.81 1,371 9,297,606
2008-02-19 2008-02-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 5,640 473,196,910 0.00 3.81 21,478 1,802,028,473
2008-02-08 2008-02-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 600 3,441,110 0.02 3.40 2,038 11,686,010
2008-02-08 2008-02-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 9,400 47,313,970 0.02 3.40 31,922 160,678,242
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 21,000 2,440,510 0.87 3.71 77,914 9,054,780
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 120 2,419,510 0.00 3.68 442 8,903,797
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 329,000 47,304,570 0.70 3.71 1,220,656 175,509,416
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 1,880 46,975,570 0.00 3.68 6,918 172,870,098
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 9,060 2,419,390 0.38 3.79 34,314 9,163,198
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 6,060 2,410,330 0.25 3.75 22,725 9,038,738
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 141,940 46,973,690 0.30 3.79 537,584 177,908,154
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 94,940 46,831,750 0.20 3.75 356,025 175,619,062
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 8,400 2,404,270 0.35 3.87 32,495 9,300,678
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 33,000 2,320,270 1.44 3.88 128,056 9,003,808
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 131,600 46,736,810 0.28 3.87 509,081 180,796,676
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares
P - Purchase 517,000 46,605,210 1.12 3.88 2,006,218 180,851,517
2008-02-05 2008-02-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 42,000 2,322,870 1.84 3.69 155,022 8,573,713
2008-02-05 2008-02-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 658,000 46,088,210 1.45 3.69 2,428,678 170,111,583
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 30,000 2,320,870 1.31 3.43 102,987 7,967,315
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 23,640 2,290,870 1.04 3.50 82,723 8,016,441
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 470,000 45,430,210 1.05 3.43 1,613,463 155,957,368
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 370,360 44,960,210 0.83 3.50 1,296,001 157,329,263
2008-02-01 2008-01-30 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 15,000 2,267,230 0.67 3.23 48,456 7,324,060
2008-02-01 2008-01-30 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 235,000 44,589,850 0.53 3.23 759,144 144,043,051
2008-01-30 2008-01-29 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,000 2,252,230 0.27 3.23 19,379 7,274,252
2008-01-30 2008-01-29 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 94,000 44,354,850 0.21 3.23 303,601 143,257,295
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 600 2,246,230 0.03 3.23 1,938 7,255,323
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 40,200 2,245,630 1.82 3.21 129,203 7,217,455
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 9,400 44,260,850 0.02 3.23 30,362 142,962,546
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 629,800 44,251,450 1.44 3.21 2,024,177 142,224,160
2008-01-29 2008-01-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 12,000 2,205,430 0.55 3.24 38,856 7,141,182
2008-01-29 2008-01-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 188,000 43,621,650 0.43 3.24 608,744 141,246,903
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 42,300 2,193,430 1.97 2.99 126,477 6,558,356
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 13,800 2,151,130 0.65 2.98 41,124 6,410,367
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 66,270 43,433,650 0.15 2.99 198,147 129,866,614
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 216,200 42,770,950 0.51 2.98 644,276 127,457,431
2008-01-28 2008-01-23 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 18,000 2,137,330 0.85 2.88 51,908 6,163,632
2008-01-28 2008-01-23 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 282,000 42,554,750 0.67 2.88 813,232 122,719,388
2008-01-25 2008-01-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 790 2,119,330 0.04 2.90 2,293 6,151,355
2008-01-25 2008-01-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 12,520 42,272,750 0.03 2.90 36,339 122,696,657
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 7,560 2,118,540 0.36 3.16 23,888 6,694,163
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 11,820 2,110,980 0.56 3.13 36,994 6,606,945
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 118,440 42,260,230 0.28 3.16 374,247 133,533,875
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 185,180 42,141,790 0.44 3.13 579,576 131,895,374
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 11,460 2,099,160 0.55 3.01 34,444 6,309,235
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 9,240 2,087,700 0.44 3.06 28,240 6,380,638
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 144,760 41,956,610 0.35 3.06 442,430 128,231,987
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 179,540 41,811,850 0.43 3.01 539,625 125,669,696
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 27,600 2,078,460 1.35 3.06 84,346 6,351,774
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 180 2,008,860 0.01 3.16 568 6,341,368
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 432,400 41,632,310 1.05 3.10 1,340,440 129,060,161
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 2,820 41,199,910 0.01 3.16 8,902 130,055,756
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 42,000 2,050,680 2.09 3.11 130,712 6,382,126
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 15,000 2,008,680 0.75 3.06 45,909 6,147,766
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 658,000 41,197,090 1.62 3.11 2,047,828 128,213,583
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 235,000 40,539,090 0.58 3.06 719,241 124,073,939
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 27,600 2,078,460 1.35 3.10 85,560 6,443,226
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 180 2,050,860 0.01 3.16 568 6,473,950
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 432,400 41,632,310 1.05 3.10 1,340,440 129,060,161
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 2,820 41,199,910 0.01 3.16 8,902 130,055,756
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 42,000 2,050,680 2.09 3.11 130,712 6,382,126
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 15,000 2,008,680 0.75 3.06 45,909 6,147,766
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 658,000 41,197,090 1.62 3.11 2,047,828 128,213,583
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 235,000 40,539,000 0.58 3.06 719,241 124,073,663
2008-01-15 2008-01-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 22,200 1,993,680 1.13 3.41 75,724 6,800,442
2008-01-15 2008-01-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 347,800 40,304,090 0.87 3.41 1,186,346 137,477,251
2008-01-15 2008-01-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 28,320 1,971,480 1.46 3.39 96,076 6,688,246
2008-01-15 2008-01-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 443,680 39,956,290 1.12 3.39 1,505,184 135,551,714
2008-01-11 2008-01-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 69,000 1,943,160 3.68 3.30 227,748 6,413,788
2008-01-11 2008-01-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 1,081,000 39,521,610 2.81 3.30 3,568,057 130,448,978
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 36,000 1,874,160 1.96 3.27 117,896 6,137,687
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 24,060 1,838,160 1.33 3.30 79,283 6,057,105
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 564,000 37,431,610 1.53 3.27 1,847,044 122,584,780
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 376,940 37,867,610 1.01 3.30 1,242,093 124,781,348
2008-01-11 2008-01-08 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 30,000 1,814,100 1.68 3.26 97,743 5,910,519
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 20,000 1,784,100 1.13 2.87 57,372 5,117,869
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 81,600 1,764,100 4.85 3.11 253,401 5,478,236
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 6,000 1,682,500 0.36 3.10 18,600 5,215,750
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 1,278,400 37,020,670 3.58 3.11 3,969,943 114,963,989
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 94,000 35,742,270 0.26 3.10 291,400 110,801,037
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 180,000 35,648,270 0.51 2.87 516,348 102,260,627
2008-01-11 2007-01-08 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 470,000 37,490,670 1.27 3.26 1,531,307 122,148,352
2008-01-04 2008-01-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 1,222,000 35,045,270 3.61 2.89 3,531,580 101,280,830
2008-01-04 2007-01-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 78,000 1,649,500 4.96 2.89 225,420 4,767,055
2008-01-02 2007-12-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 69,000 1,571,500 4.59 2.74 188,750 4,298,838
2008-01-02 2007-12-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 1,081,000 33,823,270 3.30 2.74 2,957,076 92,523,555
2008-01-02 2007-12-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 48,000 1,502,500 3.30 2.69 129,226 4,045,030
2008-01-02 2007-12-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 752,000 32,742,270 2.35 2.69 2,024,534 88,148,739
2007-12-31 2007-12-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 18,000 1,454,500 1.25 2.60 46,717 3,775,009
2007-12-31 2007-12-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
P - Purchase 282,000 31,990,270 0.89 2.60 731,903 83,027,547
2007-12-31 3/A XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
31,708,270
2007-12-07 3 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
27,876,060
2007-12-07 3 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares
1,436,500
2004-08-19 2004-08-16 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock
S - Sale -200 7,250 -2.68 5.50 -1,100 39,875
2004-08-19 2004-08-16 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock
P - Purchase 200 7,450 2.76 5.10 1,020 37,995
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)